Article
Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder.
Scientific reports - 30 Jan 2018
Pagerols Mireia, Richarte Vanesa, Sánchez-Mora Cristina, Rovira Paula, Soler Artigas María, Garcia-Martínez Iris, Calvo-Sánchez Eva, Corrales Montse, da Silva Bruna Santos, Mota Nina Roth, Victor Marcelo Moraes, Rohde Luis Augusto, Grevet Eugenio Horacio, Bau Claiton Henrique Dotto, Cormand Bru, Casas Miguel, Ramos-Quiroga Josep Antoni, Ribasés Marta
Abstract excerpt
Methylphenidate (MPH) is the most frequently used pharmacological treatment in children with attention-deficit/hyperactivity disorder (ADHD). However, a considerable interindividual variability exists in clinical outcome. Thus, we performed a genome-wide association study of MPH efficacy in 173 ADHD paediatric patients. Although no variant reached genome-wide significance, the set of genes containing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
